SCHEMBL21033056

SCHEMBL21033056

COc1ccc(S(=O)(=O)c2cc3cc(Br)cc(Br)c3oc2=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 3/20 0.64
▸ TP53 P04637 2/20 0.64
▸ MAPT P10636 3/20 0.60
▸ THRB P10828 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ PKM P14618 5/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ GLA P06280 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ LMNA P02545 3/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MAOB P27338 4/20 0.49
▸ CA12 O43570 2/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ GPR35 Q9HC97 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21033127 0.89 TP53 (0.80) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21033402 0.84 RXFP1 (0.55) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21033400 0.83 LMNA (0.69) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21033403 0.81 ATM (0.55) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21033121 0.81 RXFP1 (0.81) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL20435649 0.79 MAPT (0.76) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21032944 0.79 TP53 (0.79) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL21032942 0.78 RXFP1 (1.00) RXFP1TP53MAPTTHRBSMN1; SMN2
SCHEMBL11297367 0.77 MAOB (0.79) RXFP1MAPTMEN1KMT2AMAOB
SCHEMBL21032749 0.77 RXFP1 (0.69) RXFP1TP53MAPTTHRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104201-A1 SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY IN NON-HUMANS Zander Therapeutics, Inc. (US) 2019-05-31 — — WO disclosed
WO-2019104199-A1 SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY REGEN BIOPHARMA INC. (US) 2019-05-31 — — WO disclosed
Send feedback